Skip to main content

Maxcyte, Inc.

MXCT
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001287098

In the last 90 days, Maxcyte, Inc. insiders filed 1 open-market purchase and 0 sales; 118 institutions reported holding it in 13F filings for Q3 2026, worth $72.6M in total; no superinvestor holds it.

Holders of 5% or more of MXCT

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Maxcyte, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of MXCT
HolderLatest formStakeChangeFirst filedLatest filingFiling
Capricorn Fund Managers Ltd13G7.70%8.20M sharesNewFeb 5, 20261 filingFeb 5, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

35 Schedule 13D and 13G filings on Maxcyte, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on MXCT
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 2, 202610:19 AM ETLiontrust Investment Partners LLP13D4.90%5.08M shares−0.10 ppfrom 5.00%Below 5%Oct 30, 2026SEC
Oct 15, 20269:00 AM ETLiontrust Investment Partners LLP13D5.00%5.19M sharesNewOct 14, 2026SEC
Aug 4, 20268:42 AM ETRiver & Mercantile Asset Management LLP13D0.80%834.1K shares−5.30 ppfrom 6.10%Below 5%Jul 31, 2026SEC
Jul 29, 20263:19 PM ETBlackRock, Inc.13G/A1.30%1.40M shares−5.30 ppfrom 6.60%Below 5%Jun 30, 2026SEC
May 14, 20269:44 AM ETRiver & Mercantile Asset Management LLP13D6.10%6.53M shares+0.90 ppfrom 5.20%May 13, 2026SEC
Apr 10, 202610:16 AM ETMirabella Financial Services LLP13G/A0.00%0 shares−7.69 ppfrom 7.69%Below 5%Mar 31, 2026SEC
Mar 27, 202610:34 AM ETVanguard Group Inc13G/A0.00%0 shares–Below 5%Mar 13, 2026SEC
Feb 17, 20262:28 PM ETCadian Capital Management, LPand 2 others13G/A3.50%3.68M shares−4.20 ppfrom 7.70%Below 5%Dec 31, 2025SEC
Feb 5, 20268:03 AM ETCapricorn Fund Managers Ltd13G7.70%8.20M sharesNewJan 30, 2026SEC
Jan 21, 202612:30 PM ETBlackRock, Inc.13G/A6.60%7.00M shares−1.20 ppfrom 7.80%Dec 31, 2025SEC
Nov 14, 20251:40 PM ETCadian Capital Management, LPand 2 others13G/A7.70%8.23M shares−1.20 ppfrom 8.90%Sep 30, 2025SEC
Nov 4, 20259:38 AM ETMirabella Financial Services LLP13G/A7.69%8.20M shares+1.49 ppfrom 6.20%Sep 30, 2025SEC
Nov 3, 202511:23 AM ETMirabella Financial Services LLP13G6.20%6.60M sharesNewJun 30, 2025SEC
Oct 24, 202511:50 AM ETRiver & Mercantile Asset Management LLP13D5.20%5.50M sharesNewSep 23, 2025SEC
Feb 13, 20256:17 PM ETCadian Capital Management, LPand 2 others13G/A8.90%9.34M shares–Dec 31, 2024SEC
Feb 5, 20255:28 PM ETBlackRock, Inc.13G/A7.80%8.26M shares–Dec 31, 2024SEC
Nov 13, 2024Cadian Capital Management, LP13G/AOld format–––SEC
Nov 8, 2024BlackRock, Inc.13G/AOld format–––SEC
Oct 31, 2024Integrated Core Strategies (US) LLC13G/AOld format–––SEC
Oct 21, 2024BlackRock, Inc.13G/AOld format–––SEC
Mar 25, 2024Integrated Core Strategies (US) LLC13GOld format–––SEC
Feb 14, 2024Cadian Capital Management, LP13GOld format–New–SEC
Feb 14, 2024Casdin Capital, LLC13G/AOld format–––SEC
Feb 13, 2024Vanguard Group Inc13GOld format–New–SEC
Feb 1, 2024Integrated Core Strategies (US) LLC13G/AOld format–––SEC
Jan 26, 202411:49 AM ETBlackRock Inc.13G/AOld format–––SEC
Nov 17, 2023Integrated Core Strategies (US) LLC13GOld format–New–SEC
Feb 14, 2023Bamco Inc13G/AOld format–––SEC
Feb 13, 2023Sofinnova Crossover I13G/AOld format–––SEC
Jan 31, 20231:58 PM ETBlackRock Inc.13G/AOld format–––SEC
Jan 10, 2023Casdin Capital, LLC13G/AOld format–––SEC
Feb 15, 2022Bamco Inc13GOld format–New–SEC
Feb 11, 2022Sofinnova Crossover I13GOld format–New–SEC
Feb 4, 20224:12 PM ETBlackRock Inc.13GOld format–New–SEC
Aug 3, 2021Casdin Capital, LLC13GOld format–New–SEC

Form 144: proposed insider sales

11 notices from officers, directors and other affiliates planning to sell Maxcyte, Inc. shares, newest first.

Form 144 notices for MXCT
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Jun 25, 20254:05 PM ETHemrajani RekhaDirector10.7K$22.4KJun 25, 202510b5-1Stifel Nicolaus & Company IncSEC
Dec 26, 20244:16 PM ETJohnston John JosephAffiliate12.0K$49.3KDec 26, 202410b5-1Stifel Nicolaus & Company Inc.SEC
Sep 26, 20244:11 PM ETJohnston John JosephAffiliate9.00K$34.3KSep 26, 202410b5-1Stifel Nicolaus & Company Inc.SEC
Sep 3, 20244:36 PM ETErck Stanley COfficer143.1K$618.0KSep 3, 202410b5-1Stifel Nicolaus & Company Inc.SEC
Jun 27, 20244:21 PM ETJohnston John JosephAffiliate16.0K$63.7KJun 27, 202410b5-1Stifel Nicolaus & Company Inc.SEC
Jun 20, 20244:21 PM ETRoss Thomas M.Officer133.3K$588.0KJun 20, 202410b5-1Stifel Nicolaus & Company Inc.SEC
Feb 26, 20244:22 PM ETJohnston John JosephAffiliate10.0K$45.9KFeb 26, 202410b5-1Stifel Nicolaus & Company Inc.SEC
Nov 29, 20234:32 PM ETDoerfler DouglasOfficer150.0K$702.0KNov 29, 202310b5-1Stifel Nicolaus & Company IncSEC
Nov 14, 20234:47 PM ETJohnston John JosephAffiliate20.0K$74.2KNov 14, 202310b5-1Stifel Nicolaus & Company Inc.SEC
Jul 10, 20234:51 PM ETDoerfler DouglasOfficer90.0K$416.7KJul 10, 202310b5-1Stifel InvestmentsSEC
Jun 26, 20234:34 PM ETJohnston John JosephAffiliate25.0K$117.0KJun 26, 202310b5-1Stifel InvestmentsSEC